FDA Approve System Based on Space Technology
The ClearSight system from Edwards Lifesciences, which offers non-invasive hemodynamic monitoring, has been approved by the FDA. The ClearSystem works in a similar way to the ccNexfin technology, which was developed for monitoring the health of astronauts in space. The system consists of an inflatable finger cuff, minimally invasive catheters and a finger heart reference sensor.
Traditionally, advanced hemodynamic information was gathered using a pulmonary artery catheter. However, this method is invasive and difficult on the patient, particularly those who are weakened by stroke or heart failure. The ClearSight system offers a minimally invasive way to obtain vital information such as stroke volume, stroke volume variation, cardiac output and systemic volume variation. Hopefully this will allow many more ICU patients to undergo close monitoring which is so vital to their care.